Skip to main content

Table 5 Comparision for 4 models and clinical features

From: Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma

Characteristics

C-index (95%CI)

1-year AUC (95%CI)

3-year AUC (95%CI)

5-year AUC (95%CI)

T

0.50 (0.426–0.583, 0.571)

0.53 (0.47–0.6)

0.52 (0.46–0.58)

0.6 (0.52–0.67)

N

0.53 (0.452–0.610,0.835)

0.52 (0.47–0.59)

0.53 (0.47–0.59)

0.45 (0.46–0.54)

Age

0.56 (0.490–0.626,0.0096)

0.62 (0.53–0.71)

0.55 (0.48–0.62)

0.51 (0.42–0.6)

AJCC stage

0.52 (0.434–0.600,0.412)

0.56 (0.5–0.63)

0.58 (0.52–0.64)

0.5 (0.41–0.59)

14-IGPS signature

0.78 (0.693–0.859,3.65E-08)

0.73 (0.66–0.8)

0.82 (0.77–0.87)

0.75 (0.66–0.82)

3-gene signature

0.67 (0.579–0.767, 0.002)

0.56 (0.48–0.63)

0.64 (0.57–0.71)

0.63 (0.52–0.74)

6-gene signature

0.65 (0.560–0.750, 7.07E-5)

0.56 (0.48–0.63)

0.63 (0.56–0.7)

0.71 (0.62–0.81)

3-gene signature

0.62 (0.519–0.715,0.043

0.59 (0.50–0.67)

0.58 (0.51–0.66)

0.51 (0.40–0.61)